Angela Tang, MD
Obstetrics & Gynecology · Providence, RINPI 1487108098
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Daiichi Sankyo Inc. at 28.7% of the total. Reporting peaked in 2021 at $565 and has fallen 94.9% since, to $29 in 2025.
Across 101 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$450
- AbbVie$302
- Astellas Pharma US Inc$132
- Therapeuticsmd, Inc.$122
- Organon$114
- Urovant Sciences Inc$106
- plus $343 from 14 others
What the payments were for
- Food & beverage$1,568100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 24 | $450 |
| AbbVie | 22 | $302 |
| Astellas Pharma US Inc | 9 | $132 |
| Therapeuticsmd, Inc. | 8 | $122 |
| Organon | 9 | $114 |
| Urovant Sciences Inc | 7 | $106 |
| Pfizer | 3 | $64 |
| Myovant Sciences Inc. | 3 | $49 |
| Merck | 3 | $36 |
| Bayer | 2 | $32 |
| Livanova USA, Inc. | 1 | $21 |
| Minerva Surgical, Inc | 1 | $20 |
| Mayne Pharma Commercial LLC | 2 | $19 |
| Agile Therapeutics, Inc. | 1 | $18 |
| Axonics, Inc. | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Exeltis, USA Inc. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Aspira Women's Health Inc | 1 | $13 |
| Alydia Health | 1 | $7 |
How this compares
$1,568 in reported general payments places this provider in the 70th percentile of 139 obstetrics & gynecology providers in Rhode Island.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 24 | $1,422 |
| Metronidazole | 14 | $446 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Providence
- Warren HuberProvidence$50K
- Lisa BoyleProvidence$30K
- Renee EgerProvidence$24K
- Gary WhartonProvidence$22K
- Christine FoleyProvidence$21K
- Cara MathewsProvidence$21K
- Michael BeitleProvidence$9K
- Ogechukwu EzikeProvidence$7K
- Beata DizoglioProvidence$6K
- Michele GangeProvidence$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.